Why it matters
The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
Project record
At a glance
- Company
- Eli Lilly
- Industry
- Pharmaceuticals
- Location
- Houston, Texas
- Investment
- $6.50B
- Permanent jobs announced
- 615
- Status
- Planning
- Announced
- Sep 23, 2025
- Expected opening
- Jan 1, 2030
- Added to tracker
- Feb 10, 2026
Sources
Official references
- Primary source https://investor.lilly.com/news-releases/news-release-details/lilly-plans-build-new-65-billion-facility-manufacture-active
Related
Other projects to know
In Texas
- Building MaterialsUSGOrange, Texas$1.18B200 jobs
- Critical Minerals ProcessingMP MaterialsNorthlake, Texas$1.25B1,500 jobs
- Advanced ManufacturingNVIDIA / Foxconn (AI Supercomputer)Houston, Texas$700.0M1,500 jobs
- Advanced ManufacturingApple / Foxconn (Server Manufacturing)Houston, Texas$500.0M1,200 jobs
Back to the tracker/projects/eli-lilly-houston